CRMLN: Procedures for Certification of Manufacturers
A manufacturer seeking certification by CDC must collaborate with a CRMLN member laboratory on a method comparison study. The manufacturer is responsible for providing the sera used in the study, and provides the reference measurements for the samples. CDC’s Lipids Reference Laboratory evaluates the measurement results generated by the CRMLN member laboratory and the manufacturer, and issues a certificate to the manufacturer if it meets required analytical performance criteria.
Separate protocols for obtaining new certificates and a simplified protocol for obtaining recertification are used for total cholesterol measurements. Recertification protocols for HDL-C and LDL-C are currently not available. Certificates for manufacturers expire two years after the date they are issued.
Whether or not measurement results obtained from commercial tests are in line with those from CRMLN reference methods is assessed, using established protocols such as the Clinical and Laboratory Standards Institute (CLSI) Protocol EP9-A, “Method Comparison and Bias Estimation Using Patient Samples.” This protocol requires analyzing a minimum of 40 patient specimens by both the test method and reference method. The mean bias among all patient samples between the test method and the reference method is calculated and the imprecision is determined. The mean bias is an estimation of the calibration bias. Current performance criteria are:
Separate certificates are issued for comparison studies using spectrophotometric and mass spectrometric reference methods.
Manufacturers Certification Protocols
- Total Cholesterol Certification Program for Manufacturers (Revised)
[PDF – 442 KB] October 2004
- Total Cholesterol Recertification Protocol for Manufacturers
[PDF – 635 KB] October 2004
- HDL Cholesterol Certification Protocol for Manufacturers
[PDF – 313 KB] November 2002
- LDL Cholesterol Certification Protocol for Manufacturers
[PDF – 476 KB] June 2006
Use of trade names is for identification only and does not constitute endorsement by the CDC or the U.S. Department of Health and Human Services.
- Page last reviewed: July 6, 2017
- Page last updated: July 6, 2017
- Content source: